Clinical Study
Clinical Usefulness of Cancer Markers in Primary Breast Cancer
Table 4
The combination of tumor markers with the sensitivity and specificity.
| | Tumor marker combination | Sensitivity | Specificity |
| | CA 549 + MSA | 44% | 82% | | CA 549 + CA 15-3 | 49% | 77% | | MSA + CA 15-3 | 44% | 79% | | MSA + CA 15-3 + CA 549 | 53% | 73 |
|
|
